rs6657048

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_198576.4(AGRN):​c.261C>T​(p.Asp87Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0162 in 1,613,184 control chromosomes in the GnomAD database, including 425 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 123 hom., cov: 34)
Exomes 𝑓: 0.015 ( 302 hom. )

Consequence

AGRN
NM_198576.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.21

Publications

6 publications found
Variant links:
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
AGRN Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 1-1022260-C-T is Benign according to our data. Variant chr1-1022260-C-T is described in ClinVar as Benign. ClinVar VariationId is 128296.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.21 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0665 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGRNNM_198576.4 linkc.261C>T p.Asp87Asp synonymous_variant Exon 2 of 36 ENST00000379370.7 NP_940978.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGRNENST00000379370.7 linkc.261C>T p.Asp87Asp synonymous_variant Exon 2 of 36 1 NM_198576.4 ENSP00000368678.2
AGRNENST00000620552.4 linkc.-154C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 2 of 39 5 ENSP00000484607.1
AGRNENST00000620552.4 linkc.-154C>T 5_prime_UTR_variant Exon 2 of 39 5 ENSP00000484607.1

Frequencies

GnomAD3 genomes
AF:
0.0288
AC:
4384
AN:
152188
Hom.:
123
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0687
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.0108
Gnomad ASJ
AF:
0.0187
Gnomad EAS
AF:
0.00538
Gnomad SAS
AF:
0.0356
Gnomad FIN
AF:
0.00443
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0146
Gnomad OTH
AF:
0.0287
GnomAD2 exomes
AF:
0.0181
AC:
4549
AN:
250898
AF XY:
0.0187
show subpopulations
Gnomad AFR exome
AF:
0.0726
Gnomad AMR exome
AF:
0.00633
Gnomad ASJ exome
AF:
0.0168
Gnomad EAS exome
AF:
0.00413
Gnomad FIN exome
AF:
0.00508
Gnomad NFE exome
AF:
0.0143
Gnomad OTH exome
AF:
0.0135
GnomAD4 exome
AF:
0.0148
AC:
21676
AN:
1460878
Hom.:
302
Cov.:
33
AF XY:
0.0155
AC XY:
11265
AN XY:
726746
show subpopulations
African (AFR)
AF:
0.0725
AC:
2427
AN:
33480
American (AMR)
AF:
0.00729
AC:
326
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0187
AC:
489
AN:
26136
East Asian (EAS)
AF:
0.00189
AC:
75
AN:
39696
South Asian (SAS)
AF:
0.0363
AC:
3127
AN:
86258
European-Finnish (FIN)
AF:
0.00644
AC:
338
AN:
52468
Middle Eastern (MID)
AF:
0.0243
AC:
140
AN:
5768
European-Non Finnish (NFE)
AF:
0.0124
AC:
13743
AN:
1111970
Other (OTH)
AF:
0.0167
AC:
1011
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1366
2733
4099
5466
6832
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
534
1068
1602
2136
2670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0288
AC:
4387
AN:
152306
Hom.:
123
Cov.:
34
AF XY:
0.0281
AC XY:
2092
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0686
AC:
2849
AN:
41544
American (AMR)
AF:
0.0108
AC:
165
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0187
AC:
65
AN:
3470
East Asian (EAS)
AF:
0.00520
AC:
27
AN:
5188
South Asian (SAS)
AF:
0.0358
AC:
173
AN:
4830
European-Finnish (FIN)
AF:
0.00443
AC:
47
AN:
10620
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0146
AC:
993
AN:
68028
Other (OTH)
AF:
0.0279
AC:
59
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
213
427
640
854
1067
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0199
Hom.:
83
Bravo
AF:
0.0307
Asia WGS
AF:
0.0190
AC:
67
AN:
3478
EpiCase
AF:
0.0172
EpiControl
AF:
0.0154

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Sep 21, 2020
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 03, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Congenital myasthenic syndrome 8 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
0.59
DANN
Benign
0.87
PhyloP100
-2.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6657048; hg19: chr1-957640; COSMIC: COSV65070021; API